ID   TF3C4_HUMAN             Reviewed;         822 AA.
AC   Q9UKN8; Q5VZJ7;
DT   07-JUN-2004, integrated into UniProtKB/Swiss-Prot.
DT   04-NOV-2008, sequence version 2.
DT   10-MAY-2017, entry version 133.
DE   RecName: Full=General transcription factor 3C polypeptide 4;
DE            EC=2.3.1.48;
DE   AltName: Full=TF3C-delta;
DE   AltName: Full=Transcription factor IIIC 90 kDa subunit;
DE            Short=TFIIIC 90 kDa subunit;
DE            Short=TFIIIC90;
DE   AltName: Full=Transcription factor IIIC subunit delta;
GN   Name=GTF3C4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 139-156; 170-179;
RP   614-626 AND 643-659, AND INTERACTION WITH GTF3C1; GTF3C2; GTF3C5;
RP   BRF1; POLR3C AND POLR3F.
RX   PubMed=10523658; DOI=10.1128/MCB.19.11.7697;
RA   Hsieh Y.-J., Kundu T.K., Wang Z., Kovelman R., Roeder R.G.;
RT   "The TFIIIC90 subunit of TFIIIC interacts with multiple components of
RT   the RNA polymerase III machinery and contains a histone-specific
RT   acetyltransferase activity.";
RL   Mol. Cell. Biol. 19:7697-7704(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, Placenta, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   IDENTIFICATION IN TFIIIC COMPLEX, AND INTERACTION WITH GTF3C6.
RX   PubMed=17409385; DOI=10.1074/jbc.M611542200;
RA   Dumay-Odelot H., Marck C., Durrieu-Gaillard S., Lefebvre O.,
RA   Jourdain S., Prochazkova M., Pflieger A., Teichmann M.;
RT   "Identification, molecular cloning, and characterization of the sixth
RT   subunit of human transcription factor TFIIIC.";
RL   J. Biol. Chem. 282:17179-17189(2007).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-611, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-611, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-611, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-611, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-611, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-19; SER-604; SER-611 AND
RP   SER-652, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: Essential for RNA polymerase III to make a number of
CC       small nuclear and cytoplasmic RNAs, including 5S RNA, tRNA, and
CC       adenovirus-associated (VA) RNA of both cellular and viral origin.
CC       Has histone acetyltransferase activity (HAT) with unique
CC       specificity for free and nucleosomal H3. May cooperate with GTF3C5
CC       in facilitating the recruitment of TFIIIB and RNA polymerase
CC       through direct interactions with BRF1, POLR3C and POLR3F. May be
CC       localized close to the A box.
CC   -!- CATALYTIC ACTIVITY: Acetyl-CoA + [protein]-L-lysine = CoA +
CC       [protein]-N(6)-acetyl-L-lysine.
CC   -!- SUBUNIT: Part of the TFIIIC subcomplex TFIIIC2, consisting of six
CC       subunits, GTF3C1, GTF3C2, GTF3C3, GTF3C4, GTF3C5 and GTF3C6.
CC       Interacts with BRF1, GTF3C1, GTF3C2, GTF3C5, GTF3C6, POLR3C and
CC       POLR3F. {ECO:0000269|PubMed:10523658,
CC       ECO:0000269|PubMed:17409385}.
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- SIMILARITY: Belongs to the TFIIIC subunit 4 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH11619.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF142328; AAF05087.1; -; mRNA.
DR   EMBL; AL160165; CAH70534.1; -; Genomic_DNA.
DR   EMBL; CH471090; EAW88011.1; -; Genomic_DNA.
DR   EMBL; BC011619; AAH11619.1; ALT_SEQ; mRNA.
DR   EMBL; BC094774; AAH94774.1; -; mRNA.
DR   EMBL; BC104755; AAI04756.1; -; mRNA.
DR   EMBL; BC112245; AAI12246.1; -; mRNA.
DR   CCDS; CCDS6953.1; -.
DR   RefSeq; NP_036336.2; NM_012204.3.
DR   UniGene; Hs.22302; -.
DR   UniGene; Hs.656646; -.
DR   ProteinModelPortal; Q9UKN8; -.
DR   BioGrid; 114738; 65.
DR   IntAct; Q9UKN8; 20.
DR   STRING; 9606.ENSP00000361219; -.
DR   iPTMnet; Q9UKN8; -.
DR   PhosphoSitePlus; Q9UKN8; -.
DR   BioMuta; GTF3C4; -.
DR   DMDM; 212276467; -.
DR   EPD; Q9UKN8; -.
DR   MaxQB; Q9UKN8; -.
DR   PaxDb; Q9UKN8; -.
DR   PeptideAtlas; Q9UKN8; -.
DR   PRIDE; Q9UKN8; -.
DR   Ensembl; ENST00000372146; ENSP00000361219; ENSG00000125484.
DR   GeneID; 9329; -.
DR   KEGG; hsa:9329; -.
DR   UCSC; uc010mzv.4; human.
DR   CTD; 9329; -.
DR   GeneCards; GTF3C4; -.
DR   HGNC; HGNC:4667; GTF3C4.
DR   HPA; HPA069369; -.
DR   MIM; 604892; gene.
DR   neXtProt; NX_Q9UKN8; -.
DR   OpenTargets; ENSG00000125484; -.
DR   PharmGKB; PA29055; -.
DR   eggNOG; ENOG410IDZI; Eukaryota.
DR   eggNOG; ENOG410YTGT; LUCA.
DR   GeneTree; ENSGT00390000011873; -.
DR   HOGENOM; HOG000121774; -.
DR   HOVERGEN; HBG059337; -.
DR   InParanoid; Q9UKN8; -.
DR   KO; K11310; -.
DR   OMA; NGRCLLA; -.
DR   OrthoDB; EOG091G060P; -.
DR   PhylomeDB; Q9UKN8; -.
DR   TreeFam; TF328412; -.
DR   Reactome; R-HSA-749476; RNA Polymerase III Abortive And Retractive Initiation.
DR   Reactome; R-HSA-76061; RNA Polymerase III Transcription Initiation From Type 1 Promoter.
DR   Reactome; R-HSA-76066; RNA Polymerase III Transcription Initiation From Type 2 Promoter.
DR   ChiTaRS; GTF3C4; human.
DR   GeneWiki; GTF3C4; -.
DR   GenomeRNAi; 9329; -.
DR   PRO; PR:Q9UKN8; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000125484; -.
DR   CleanEx; HS_GTF3C4; -.
DR   ExpressionAtlas; Q9UKN8; baseline and differential.
DR   Genevisible; Q9UKN8; HS.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0000127; C:transcription factor TFIIIC complex; IDA:HGNC.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0008047; F:enzyme activator activity; TAS:ProtInc.
DR   GO; GO:0004402; F:histone acetyltransferase activity; TAS:ProtInc.
DR   GO; GO:0042791; P:5S class rRNA transcription from RNA polymerase III type 1 promoter; IC:HGNC.
DR   GO; GO:0006383; P:transcription from RNA polymerase III promoter; IC:HGNC.
DR   GO; GO:0006384; P:transcription initiation from RNA polymerase III promoter; TAS:ProtInc.
DR   GO; GO:0006351; P:transcription, DNA-templated; IC:HGNC.
DR   GO; GO:0042797; P:tRNA transcription from RNA polymerase III promoter; IC:HGNC.
DR   Gene3D; 2.130.10.10; -; 1.
DR   InterPro; IPR024761; TFIIIC_delta_N.
DR   InterPro; IPR024764; TFIIIC_Znf.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom.
DR   InterPro; IPR017986; WD40_repeat_dom.
DR   Pfam; PF12657; TFIIIC_delta; 1.
DR   Pfam; PF12660; zf-TFIIIC; 1.
DR   SUPFAM; SSF50978; SSF50978; 2.
PE   1: Evidence at protein level;
KW   Acetylation; Acyltransferase; Complete proteome;
KW   Direct protein sequencing; DNA-binding; Nucleus; Phosphoprotein;
KW   Reference proteome; Transcription; Transferase.
FT   CHAIN         1    822       General transcription factor 3C
FT                                polypeptide 4.
FT                                /FTId=PRO_0000209713.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:19413330}.
FT   MOD_RES      19     19       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     604    604       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     611    611       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     652    652       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   CONFLICT    268    268       C -> S (in Ref. 1; AAF05087).
FT                                {ECO:0000305}.
FT   CONFLICT    402    402       C -> R (in Ref. 1; AAF05087).
FT                                {ECO:0000305}.
FT   CONFLICT    413    413       V -> L (in Ref. 1; AAF05087).
FT                                {ECO:0000305}.
FT   CONFLICT    450    450       L -> V (in Ref. 1; AAF05087).
FT                                {ECO:0000305}.
FT   CONFLICT    483    483       S -> K (in Ref. 1; AAF05087).
FT                                {ECO:0000305}.
FT   CONFLICT    690    690       R -> P (in Ref. 1; AAF05087).
FT                                {ECO:0000305}.
SQ   SEQUENCE   822 AA;  91982 MW;  2546A1E7D87F563C CRC64;
     MNTADQARVG PADDGPAPSG EEEGEGGGEA GGKEPAADAA PGPSAAFRLM VTRREPAVKL
     QYAVSGLEPL AWSEDHRVSV STARSIAVLE LICDVHNPGQ DLVIHRTSVP APLNSCLLKV
     GSKTEVAECK EKFAASKDPT VSQTFMLDRV FNPEGKALPP MRGFKYTSWS PMGCDANGRC
     LLAALTMDNR LTIQANLNRL QWVQLVDLTE IYGERLYETS YRLSKNEAPE GNLGDFAEFQ
     RRHSMQTPVR MEWSGICTTQ QVKHNNECRD VGSVLLAVLF ENGNIAVWQF QLPFVGKESI
     SSCNTIESGI TSPSVLFWWE YEHNNRKMSG LIVGSAFGPI KILPVNLKAV KGYFTLRQPV
     ILWKEMDQLP VHSIKCVPLY HPYQKCSCSL VVAARGSYVF WCLLLISKAG LNVHNSHVTG
     LHSLPIVSMT ADKQNGTVYT CSSDGKVRQL IPIFTDVALK FEHQLIKLSD VFGSVRTHGI
     AVSPCGAYLA IITTEGMING LHPVNKNYQV QFVTLKTFEE AAAQLLESSV QNLFKQVDLI
     DLVRWKILKD KHIPQFLQEA LEKKIESSGV TYFWRFKLFL LRILYQSMQK TPSEALWKPT
     HEDSKILLVD SPGMGNADDE QQEEGTSSKQ VVKQGLQERS KEGDVEEPTD DSLPTTGDAG
     GREPMEEKLL EIQGKIEAVE MHLTREHMKR VLGEVYLHTW ITENTSIPTR GLCNFLMSDE
     EYDDRTARVL IGHISKKMNK QTFPEHCSLC KEILPFTDRK QAVCSNGHIW LRCFLTYQSC
     QSLIYRRCLL HDSIARHPAP EDPDWIKRLL QSPCPFCDSP VF
//
